Callodine Capital Management Portfolio holdings
Top Buys
| 1 |
Viatris
VTRS
|
+$29.6M |
| 2 |
Spectrum Brands
SPB
|
+$19.7M |
| 3 |
Global Payments
GPN
|
+$18.1M |
| 4 |
Blue Owl Capital
OWL
|
+$17.9M |
| 5 |
Apollo Global Management
APO
|
+$17.8M |
Top Sells
| 1 |
Equitable Holdings
EQH
|
+$52.9M |
| 2 |
Sanofi
SNY
|
+$32.9M |
| 3 |
CVS Health
CVS
|
+$23.6M |
| 4 |
SEE
Sealed Air
SEE
|
+$16.7M |
| 5 |
Reinsurance Group of America
RGA
|
+$13.8M |
Sector Composition
| 1 | Financials | 21.9% |
| 2 | Consumer Staples | 18.34% |
| 3 | Healthcare | 16.11% |
| 4 | Consumer Discretionary | 8.97% |
| 5 | Energy | 8% |
Similar funds
Callodine Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Callodine Capital Management held 62 positions worth $1.25B, up 9.1% from $1.14B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Callodine Capital Management deployed $103M of net new capital in Q4 2025, opening 9 new positions and adding to 28 existing holdings. Its largest new stake was Millrose Properties Inc: 361,647 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 27% a quarter earlier, followed by Consumer Staples and Healthcare.
On the sell side, the largest reduction was Shell, an estimated $3.68M trimmed.
- Callodine Capital Management's largest Q4 2025 buy was Millrose Properties Inc: 361,647 shares worth $10.8M.
- Callodine Capital Management added most to Viatris in Q4 2025, an estimated $29.6M increase.
- Callodine Capital Management's biggest Q4 2025 reduction was Shell, cutting an estimated $3.68M.
- Callodine Capital Management fully exited Equitable Holdings in Q4 2025, selling an estimated $52.9M.
- Callodine Capital Management's ten largest holdings make up 56% of its $1.25B portfolio in Q4 2025.
- Callodine Capital Management opened 9 new positions and closed 10 in Q4 2025.
- Callodine Capital Management's portfolio value rose 9.1% quarter-over-quarter to $1.25B.
Based on Callodine Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.